SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for Option Care Health, Inc. (OPCH) (CIK 0001014739) (OPCH) — Jul 2, 2020

Option Care Health, Inc. (OPCH) (CIK 0001014739)
Date: July 2, 2020 · CIK: 0001014739 · Accession: 0000000000-20-005965

AI Filing Summary & Sentiment

File numbers found in text: 333-239504

Date
July 2, 2020
Author
Not clearly detected
Form
UPLOAD
Company
Option Care Health, Inc. (OPCH) (CIK 0001014739)

Letter

United States securities and exchange commission logo July 2, 2020 Mike Shapiro Chief Financial Officer Option Care Health, Inc. 3000 Lakeside Drive Suite 300N Bannockburn, Illinois 60015 Re:Option Care Health, Inc. Registration Statement on Form S-3 Filed June 26, 2020 File No. 333-239504 Dear Mr. Shapiro: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Abby Adams at (202) 551-6902 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences

Show Raw Text
United States securities and exchange commission logo
July 2, 2020
Mike Shapiro
Chief Financial Officer
Option Care Health, Inc.
3000 Lakeside Drive
Suite 300N
Bannockburn, Illinois 60015
Re:Option Care Health, Inc.
Registration Statement on Form S-3
Filed June 26, 2020
File No. 333-239504
Dear Mr. Shapiro:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Abby Adams at (202) 551-6902 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences